CDMO Samsung Biologics
Business
CDMO Samsung Biologics Invests $347 Million to Acquire Land in the Incheon Free Economic Zone for Bio Campus II
Samsung Biologics, a leading contract development and manufacturing organization (CDMO), continues to grow. Already a world leader in capacity, operating three plants at its headquarters in Songdo, South Korea, the CDMO recently announced that its fourth plant will be...
Latest News
Melbourne Bullion: Maximise Your Returns and Stay Tax Compliant
If you’re thinking about buying or selling bullion in Melbourne, it’s not just about locking in a safe investment...